{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:05:51Z","timestamp":1789038351308,"version":"build-2803163510"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research Project of Jiangsu Cancer Hospital","award":["No.XHMS202401\u3001RCQY202501\u3001ZBDL202502"],"award-info":[{"award-number":["No.XHMS202401\u3001RCQY202501\u3001ZBDL202502"]}]},{"name":"Jiangsu Province \"333 Project\" High-Level Talent Training Program","award":["No.2024-3-2249"],"award-info":[{"award-number":["No.2024-3-2249"]}]},{"name":"YishanResearch Project of Jiangsu Cancer Hospital","award":["No. YSZD2024o4"],"award-info":[{"award-number":["No. YSZD2024o4"]}]},{"name":"Qunfeng Project of Jiangsu Cancer Hospital","award":["No. GFXK202503"],"award-info":[{"award-number":["No. GFXK202503"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16692-x","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:13:51Z","timestamp":1789031631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["NNMT-associated metabolic\u2013thromboinflammatory\u2013immune co-activation in heterogeneous CTC clusters: a hypothesis-generating computational framework\u201d"],"prefix":"10.1186","volume":"26","author":[{"given":"Jiayang","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minlan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"issue":"4","key":"16692_CR1","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","volume":"168","author":"AW Lambert","year":"2017","unstructured":"Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis. Cell. 2017;168(4):670\u201391.","journal-title":"Cell"},{"issue":"8","key":"16692_CR2","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","volume":"186","author":"S Gerstberger","year":"2023","unstructured":"Gerstberger S, Jiang Q, Ganesh K. Metastasis. Cell. 2023;186(8):1564\u201379.","journal-title":"Cell"},{"key":"16692_CR3","doi-asserted-by":"crossref","unstructured":"Chen L, Bode AM, Dong Z. Circulating tumor cells: moving biological insights into detection, in Theranostics. 2017: Australia. p. 2606\u20132619.","DOI":"10.7150\/thno.18588"},{"key":"16692_CR4","doi-asserted-by":"crossref","unstructured":"Labelle M, Hynes RO. The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination, in Cancer Discov. 2012: United States. p. 1091\u20139.","DOI":"10.1158\/2159-8290.CD-12-0329"},{"issue":"7","key":"16692_CR5","doi-asserted-by":"publisher","first-page":"e011651","DOI":"10.1136\/jitc-2025-011651","volume":"13","author":"MM Milhem","year":"2025","unstructured":"Milhem MM, Wise-Draper TM, Chandra S. Phase 1b\/2 study evaluating safety, efficacy and immune effects of TLR9 agonist Cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumors. J Immunother Cancer. 2025;13(7):e011651.","journal-title":"J Immunother Cancer"},{"issue":"5","key":"16692_CR6","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","volume":"158","author":"N Aceto","year":"2014","unstructured":"Aceto N, Bardia A, Miyamoto DT. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014;158(5):1110\u201322.","journal-title":"Cell"},{"key":"16692_CR7","doi-asserted-by":"crossref","unstructured":"Micalizzi DS, Maheswaran S, Haber DA. A conduit to metastasis: circulating tumor cell biology, in Genes Dev. 2017: United States. p. 1827\u20131840.","DOI":"10.1101\/gad.305805.117"},{"issue":"1","key":"16692_CR8","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1038\/s41467-026-69007-w","volume":"17","author":"GO Bobkov","year":"2026","unstructured":"Bobkov GO, Patel KJ, Lege BM. Extracellular matrix mediates circulating tumor cell clustering in triple-negative breast cancer metastasis. Nat Commun. 2026;17(1):1352.","journal-title":"Nat Commun"},{"issue":"28","key":"16692_CR9","doi-asserted-by":"publisher","first-page":"eadv7377","DOI":"10.1126\/sciadv.adv7377","volume":"11","author":"Z Que","year":"2025","unstructured":"Que Z, Xi Z, Qi D. Src\/FN1 pathway activation drives tumor cell cluster formation and metastasis in lung cancer: a promising therapeutic target. Sci Adv. 2025;11(28):eadv7377.","journal-title":"Sci Adv"},{"issue":"4","key":"16692_CR10","doi-asserted-by":"publisher","first-page":"934","DOI":"10.20892\/j.issn.2095-3941.2021.0466","volume":"18","author":"Y Sun","year":"2021","unstructured":"Sun Y, et al. Single-cell RNA sequencing reveals spatial heterogeneity and immune evasion of circulating tumor cells. Cancer Biol Med. 2021;18(4):934\u20136.","journal-title":"Cancer Biol Med"},{"issue":"6","key":"16692_CR11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrc1098","volume":"3","author":"IJ Fidler","year":"2003","unstructured":"Fidler IJ. The pathogenesis of cancer metastasis: the \u201cseed and soil\u201d hypothesis revisited. Nat Rev Cancer. 2003;3(6):453\u20138.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"16692_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011;147(2):275\u201392.","journal-title":"Cell"},{"issue":"43","key":"16692_CR13","doi-asserted-by":"publisher","first-page":"18392","DOI":"10.1073\/pnas.1012539107","volume":"107","author":"SL Stott","year":"2010","unstructured":"Stott SL, Hsu C-H, Tsukrov DI. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci U S A. 2010;107(43):18392\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7173","key":"16692_CR14","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/nature06385","volume":"450","author":"S Nagrath","year":"2007","unstructured":"Nagrath S, Sequist LV, Maheswaran S. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature. 2007;450(7173):1235\u20139.","journal-title":"Nature"},{"issue":"2","key":"16692_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrc3004","volume":"11","author":"LJ Gay","year":"2011","unstructured":"Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer. 2011;11(2):123\u201334.","journal-title":"Nat Rev Cancer"},{"key":"16692_CR16","doi-asserted-by":"crossref","unstructured":"Raskov H et al. The impact of platelets on the metastatic potential of tumour cells, in Heliyon. 2024: England. p. e34361.","DOI":"10.1016\/j.heliyon.2024.e34361"},{"issue":"1","key":"16692_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12943-021-01347-1","volume":"20","author":"MP Ward","year":"2021","unstructured":"Ward MP, Kane LE, Norris LA. Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell? Mol Cancer. 2021;20(1):59.","journal-title":"Mol Cancer"},{"key":"16692_CR18","doi-asserted-by":"publisher","first-page":"117474","DOI":"10.1016\/j.biopha.2024.117474","volume":"180","author":"C Hu","year":"2024","unstructured":"Hu C, Long L, Lou J. CTC-neutrophil interaction: a key driver and therapeutic target of cancer metastasis. Biomed Pharmacother. 2024;180:117474.","journal-title":"Biomed Pharmacother"},{"issue":"13","key":"16692_CR19","first-page":"2357","volume":"70","author":"J Cools-Lartigue","year":"2013","unstructured":"Cools-Lartigue J, et al. Neutrophil extracellular traps in cancer progression. Cell Mol Life Sci. 2013;70(13):2357\u201371.","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"16692_CR20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nrc.2016.52","volume":"16","author":"SB Coffelt","year":"2016","unstructured":"Coffelt SB, Wellenstein MD, de Visser KE. Neutrophils in cancer: neutral no more. Nat Rev Cancer. 2016;16(7):431\u201346.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"16692_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/bmb\/ldy029","volume":"128","author":"R Grecian","year":"2018","unstructured":"Grecian R, Whyte MKB, Walmsley SR. The role of neutrophils in cancer. Br Med Bull. 2018;128(1):5\u201314.","journal-title":"Br Med Bull"},{"issue":"3","key":"16692_CR22","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/HEP.0000000000000934","volume":"81","author":"Y Sun","year":"2025","unstructured":"Sun Y, Li T, Ding L. Platelet-mediated circulating tumor cell evasion from natural killer cell killing through immune checkpoint CD155-TIGIT. Hepatology. 2025;81(3):791\u2013807.","journal-title":"Hepatology"},{"key":"16692_CR23","doi-asserted-by":"crossref","unstructured":"Swierczak A, Pollard JW. Myeloid Cells in Metastasis, in Cold Spring Harb Perspect Med. 2020: United States.","DOI":"10.1101\/cshperspect.a038026"},{"issue":"8","key":"16692_CR24","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.3390\/ijms20081916","volume":"20","author":"ML Sprouse","year":"2019","unstructured":"Sprouse ML, Welte T, Boral D. PMN-MDSCs enhance CTC metastatic properties through reciprocal interactions via ROS\/Notch\/Nodal signaling. Int J Mol Sci. 2019;20(8):1916.","journal-title":"Int J Mol Sci"},{"issue":"361","key":"16692_CR25","doi-asserted-by":"publisher","first-page":"361ra138","DOI":"10.1126\/scitranslmed.aag1711","volume":"8","author":"J Park","year":"2016","unstructured":"Park J, Wysocki RW, Amoozgar Z. Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps. Sci Transl Med. 2016;8(361):361ra138.","journal-title":"Sci Transl Med"},{"issue":"7","key":"16692_CR26","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1002\/1878-0261.13675","volume":"19","author":"NK Andresen","year":"2025","unstructured":"Andresen NK, R\u00f8ssevold AH, Borgen E. Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors \u2013 a biomarker analysis of the ALICE and ICON trials. Mol Oncol. 2025;19(7):2092\u2013108.","journal-title":"Mol Oncol"},{"issue":"9","key":"16692_CR27","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/j.molonc.2015.05.009","volume":"9","author":"M Mazel","year":"2015","unstructured":"Mazel M, Jacot W, Pantel K. Frequent expression of PD-L1 on circulating breast cancer cells. Mol Oncol. 2015;9(9):1773\u201382.","journal-title":"Mol Oncol"},{"issue":"16","key":"16692_CR28","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1182\/blood-2017-05-743187","volume":"131","author":"XR Xu","year":"2018","unstructured":"Xu XR, Yousef GM, Ni H. Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents. Blood. 2018;131(16):1777\u201389.","journal-title":"Blood"},{"key":"16692_CR29","doi-asserted-by":"publisher","first-page":"106301","DOI":"10.1016\/j.phrs.2022.106301","volume":"182","author":"B Tesfamariam","year":"2022","unstructured":"Tesfamariam B, Wood SC. Targeting glycoprotein VI to disrupt platelet-mediated tumor cell extravasation. Pharmacol Res. 2022;182:106301.","journal-title":"Pharmacol Res"},{"issue":"1","key":"16692_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1182\/blood-2016-01-636399","volume":"128","author":"R Leblanc","year":"2016","unstructured":"Leblanc R, Peyruchaud O. Metastasis: new functional implications of platelets and megakaryocytes. Blood. 2016;128(1):24\u201331.","journal-title":"Blood"},{"key":"16692_CR31","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s12951-025-03522-8","volume":"23","author":"Y Su","year":"2025","unstructured":"Su Y, Leng M, Yang Q. Targeting circulating tumor cell-neutrophil interactions: nanoengineered strategies for inhibiting cancer metastasis. J Nanobiotechnol. 2025;23:449.","journal-title":"J Nanobiotechnol"},{"issue":"4","key":"16692_CR32","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"127","author":"GP Gupta","year":"2006","unstructured":"Gupta GP, Massagu\u00e9 J. Cancer metastasis: building a framework. Cell. 2006;127(4):679\u201395.","journal-title":"Cell"},{"issue":"9","key":"16692_CR33","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.molmed.2010.07.001","volume":"16","author":"K Pantel","year":"2010","unstructured":"Pantel K, Alix-Panabi\u00e8res C. Circulating tumour cells in cancer patients: challenges and perspectives. Trends Mol Med. 2010;16(9):398\u2013406.","journal-title":"Trends Mol Med"},{"issue":"8","key":"16692_CR34","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrc865","volume":"2","author":"AF Chambers","year":"2002","unstructured":"Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2002;2(8):563\u201372.","journal-title":"Nat Rev Cancer"},{"key":"16692_CR35","doi-asserted-by":"crossref","unstructured":"Wang W et al. Complex roles of nicotinamide N-methyltransferase in cancer progression, in Cell Death Dis. 2022: England. p. 267.","DOI":"10.1038\/s41419-022-04713-z"},{"issue":"5","key":"16692_CR36","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/nchembio.1204","volume":"9","author":"OA Ulanovskaya","year":"2013","unstructured":"Ulanovskaya OA, Zuhl AM, Cravatt BF. NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink. Nat Chem Biol. 2013;9(5):300\u20136.","journal-title":"Nat Chem Biol"},{"issue":"8082","key":"16692_CR37","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/s41586-025-09303-5","volume":"645","author":"J Heide","year":"2025","unstructured":"Heide J, Bilecz AJ, Patnaik S. NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity. Nature. 2025;645(8082):1051\u20139.","journal-title":"Nature"},{"key":"16692_CR38","doi-asserted-by":"crossref","unstructured":"Wang S et al. Pericyte drives the formation of circulating tumour cell-neutrophil clusters to promote colorectal cancer metastasis, in Gut. 2025: England. p. 81\u201393.","DOI":"10.1136\/gutjnl-2024-334618"},{"issue":"7758","key":"16692_CR39","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41586-019-1173-8","volume":"569","author":"MA Eckert","year":"2019","unstructured":"Eckert MA, Coscia F, Chryplewicz A. Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts. Nature. 2019;569(7758):723\u20138.","journal-title":"Nature"},{"key":"16692_CR40","doi-asserted-by":"crossref","unstructured":"Gan J, Zhang X, Guo J. The role of platelets in tumor immune evasion and metastasis: mechanisms and therapeutic implications, in Cancer Cell Int. 2025: England. p. 258.","DOI":"10.1186\/s12935-025-03877-w"},{"key":"16692_CR41","doi-asserted-by":"crossref","unstructured":"Wang P et al. Nicotinamide N-methyltransferase negatively regulates metastasis-promoting property of cancer-associated fibroblasts in lung adenocarcinoma, in Cancer Commun (Lond). 2025: United States. p. 110\u2013137.","DOI":"10.1002\/cac2.12633"},{"key":"16692_CR42","doi-asserted-by":"crossref","unstructured":"Ganesh K, Massague J. Targeting metastatic cancer, in Nat Med. 2021: United States. p. 34\u201344.","DOI":"10.1038\/s41591-020-01195-4"},{"issue":"1","key":"16692_CR43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1136\/gutjnl-2024-334618","volume":"75","author":"S Wang","year":"2026","unstructured":"Wang S, Ye G, Xu X. Pericyte drives the formation of circulating tumour cell-neutrophil clusters to promote colorectal cancer metastasis. Gut. 2026;75(1):81\u201393.","journal-title":"Gut"},{"issue":"1","key":"16692_CR44","doi-asserted-by":"publisher","first-page":"e000437","DOI":"10.1136\/bmjonc-2024-000437","volume":"3","author":"Y Yang","year":"2024","unstructured":"Yang Y, Huang G, Lian J. Circulating tumour cell clusters: isolation, biological significance and therapeutic implications. BMJ Oncol. 2024;3(1):e000437.","journal-title":"BMJ Oncol"},{"issue":"3","key":"16692_CR45","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20(3):174\u201386.","journal-title":"Nat Rev Cancer"},{"issue":"18","key":"16692_CR46","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/jnci\/80.18.1461","volume":"80","author":"KE Ugen","year":"1988","unstructured":"Ugen KE, et al. Inhibition of tumor cell-induced platelet aggregation and experimental tumor metastasis by the synthetic Gly-Arg-Gly-Asp-Ser peptide. J Natl Cancer Inst. 1988;80(18):1461\u20136.","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"16692_CR47","doi-asserted-by":"publisher","first-page":"7775","DOI":"10.1158\/0008-5472.CAN-09-2123","volume":"69","author":"H-G Kopp","year":"2009","unstructured":"Kopp H-G, Placke T, Salih HR. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity. Can Res. 2009;69(19):7775\u201383.","journal-title":"Can Res"},{"issue":"14","key":"16692_CR48","doi-asserted-by":"publisher","first-page":"e34361","DOI":"10.1016\/j.heliyon.2024.e34361","volume":"10","author":"H Raskov","year":"2024","unstructured":"Raskov H, et al. The impact of platelets on the metastatic potential of tumour cells. Heliyon. 2024;10(14):e34361.","journal-title":"Heliyon"},{"issue":"1","key":"16692_CR49","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13058-025-02185-5","volume":"28","author":"A Guha","year":"2025","unstructured":"Guha A, et al. Tumor-educated-platelets interact with breast cancer-stem-cells via P-selectin-PSGL1 and ensure stemness and metastasis through WNT-\u03b2-catenin-VEGF-VEGFR2 intra-cellular signaling: therapeutic modulation by aspirin. Breast Cancer Res. 2025;28(1):15.","journal-title":"Breast Cancer Res"},{"issue":"2","key":"16692_CR50","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-11-1872","volume":"72","author":"T Placke","year":"2012","unstructured":"Placke T, \u00d6rgel M, Schaller M. Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells. Cancer Res. 2012;72(2):440\u20138.","journal-title":"Cancer Res"},{"issue":"1","key":"16692_CR51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s43556-025-00261-y","volume":"6","author":"X Dai","year":"2025","unstructured":"Dai X, Xi M, Li J. Cancer metastasis: molecular mechanisms and therapeutic interventions. Mol Biomed. 2025;6(1):20.","journal-title":"Mol Biomed"},{"issue":"7745","key":"16692_CR52","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41586-019-0915-y","volume":"566","author":"BM Szczerba","year":"2019","unstructured":"Szczerba BM, Castro-Giner F, Vetter M. Neutrophils escort circulating tumour cells to enable cell cycle progression. Nature. 2019;566(7745):553\u20137.","journal-title":"Nature"},{"key":"16692_CR53","doi-asserted-by":"crossref","unstructured":"Grecian R, Whyte MKB, Walmsley SR. The role of neutrophils in cancer, in Br Med Bull. 2018: England. p. 5\u201314.","DOI":"10.1093\/bmb\/ldy029"},{"key":"16692_CR54","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mehy.2015.12.007","volume":"87","author":"Q Liu","year":"2016","unstructured":"Liu Q, Liao Q, Zhao Y. Myeloid-derived suppressor cells (MDSC) facilitate distant metastasis of malignancies by shielding circulating tumor cells (CTC) from immune surveillance. Med Hypotheses. 2016;87:34\u20139.","journal-title":"Med Hypotheses"},{"issue":"5","key":"16692_CR55","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","volume":"20","author":"M Labelle","year":"2011","unstructured":"Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011;20(5):576\u201390.","journal-title":"Cancer Cell"},{"issue":"15_suppl","key":"16692_CR56","doi-asserted-by":"publisher","first-page":"e14028","DOI":"10.1200\/JCO.2019.37.15_suppl.e14028","volume":"37","author":"X Wang","year":"2019","unstructured":"Wang X, Zhang G, Sun Q. PD-L1 expression on circulating tumor cells and prognosis of breast cancer patients. J Clin Oncol. 2019;37(15_suppl):e14028\u2013e14028.","journal-title":"J Clin Oncol"},{"issue":"3","key":"16692_CR57","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41419-022-04713-z","volume":"13","author":"W Wang","year":"2022","unstructured":"Wang W, et al. Complex roles of nicotinamide N-methyltransferase in cancer progression. Cell Death Dis. 2022;13(3):267.","journal-title":"Cell Death Dis"},{"issue":"2","key":"16692_CR58","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/cac2.12633","volume":"45","author":"P Wang","year":"2025","unstructured":"Wang P, Wang G, Li H. Nicotinamide N-methyltransferase negatively regulates metastasis-promoting property of cancer-associated fibroblasts in lung adenocarcinoma. Cancer Commun. 2025;45(2):110\u201337.","journal-title":"Cancer Commun"},{"issue":"9","key":"16692_CR59","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1080\/15384047.2015.1056945","volume":"16","author":"K Jung","year":"2015","unstructured":"Jung K, Sabri S, Hanson J. Elevated ARG1 expression in primary monocytes-derived macrophages as a predictor of radiation-induced acute skin toxicities in early breast cancer patients. Cancer Biol Ther. 2015;16(9):1281\u20138.","journal-title":"Cancer Biol Ther"},{"issue":"16","key":"16692_CR60","doi-asserted-by":"publisher","first-page":"e128008","DOI":"10.1172\/jci.insight.128008","volume":"4","author":"RF Rayes","year":"2019","unstructured":"Rayes RF, Mouhanna JG, Nicolau I. Primary tumors induce neutrophil extracellular traps with targetable metastasis-promoting effects. JCI Insight. 2019;4(16):e128008.","journal-title":"JCI Insight"},{"issue":"18","key":"16692_CR61","doi-asserted-by":"publisher","first-page":"e193521","DOI":"10.1172\/JCI193521","volume":"135","author":"D Scholten","year":"2025","unstructured":"Scholten D, El-Shennawy L, Jia Y. Double-positive T cells form heterotypic clusters with circulating tumor cells to foster cancer metastasis. J Clin Invest. 2025;135(18):e193521.","journal-title":"J Clin Invest"},{"key":"16692_CR62","doi-asserted-by":"crossref","unstructured":"Lai SY et al. Nicotinamide N-Methyltransferase (NNMT) and Liver Cancer: From Metabolic Networks to Therapeutic Targets, in Biomolecules. 2025: Switzerland.","DOI":"10.3390\/biom15050719"},{"issue":"11","key":"16692_CR63","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.3390\/biom15111553","volume":"15","author":"V Pompei","year":"2025","unstructured":"Pompei V, Cecati M, Serritelli EN. Small molecule inhibitors of nicotinamide N-methyltransferase enzyme for the treatment of osteosarcoma and Merkel cell carcinoma: potential for the development of a targeted therapeutic strategy. Biomolecules. 2025;15(11):1553.","journal-title":"Biomolecules"},{"key":"16692_CR64","doi-asserted-by":"publisher","first-page":"117864691769173","DOI":"10.1177\/1178646917691739","volume":"10","author":"DB Ramsden","year":"2017","unstructured":"Ramsden DB, et al. Nicotinamide N-methyltransferase in health and cancer. Int J Tryptophan Res. 2017;10:1178646917691739.","journal-title":"Int J Tryptophan Res"},{"key":"16692_CR65","unstructured":"University of, K., Identification of NNMT as a New Target to Treat Triple\u2011Negative Breast Cancer. 2026."},{"key":"16692_CR66","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.mehy.2016.05.022","volume":"93","author":"X Wang","year":"2016","unstructured":"Wang X, Sun Q, Liu Q. CTC immune escape mediated by PD-L1. Med Hypotheses. 2016;93:138\u20139.","journal-title":"Med Hypotheses"},{"issue":"4","key":"16692_CR67","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s10637-024-01448-w","volume":"42","author":"R Sangha","year":"2024","unstructured":"Sangha R, Jamal R, Spratlin J. A first-in-human phase I trial of daily oral zelenirstat, a N-myristoyltransferase inhibitor, in patients with advanced solid tumors and relapsed\/refractory B-cell lymphomas. Invest New Drugs. 2024;42(4):386\u201393.","journal-title":"Invest New Drugs"},{"issue":"16_suppl","key":"16692_CR68","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1200\/JCO.2024.42.16_suppl.3082","volume":"42","author":"RS Sangha","year":"2024","unstructured":"Sangha RS, Jamal R, Spratlin J. Final results of a first-in-human phase I dose escalation trial of daily oral zelenirstat, a N-myristoyltransferase inhibitor, in patients with advanced solid tumors and relapsed\/refractory B-cell lymphomas. J Clin Oncol. 2024;42(16_suppl):3082.","journal-title":"J Clin Oncol"},{"key":"16692_CR69","unstructured":"Kazia T. Kazia Therapeutics Reports Early Efficacy Data from First Triple\u2011Negative Breast Cancer Patient Receiving Paxalisib Combination Regimen Achieving >50% Reduction in Circulating Tumor Cells in Phase 1b Trial. 2025."},{"key":"16692_CR70","doi-asserted-by":"publisher","first-page":"117765","DOI":"10.1016\/j.bcp.2026.117765","volume":"247","author":"S-Z Bi","year":"2026","unstructured":"Bi S-Z, Ni X-L, Sun W-D. The emerging role of nicotinamide N-methyltransferase in the pathogenesis and treatment of breast cancer. Biochem Pharmacol. 2026;247:117765.","journal-title":"Biochem Pharmacol"},{"key":"16692_CR71","doi-asserted-by":"crossref","unstructured":"Amo L et al. Involvement of platelet-tumor cell interaction in immune evasion. Potential role of podocalyxin-like protein 1. Front Oncol, 2014;4:245.","DOI":"10.3389\/fonc.2014.00245"},{"key":"16692_CR72","unstructured":"National Cancer, I., Immune Checkpoint Inhibitors. 2019."},{"issue":"3","key":"16692_CR73","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3390\/ph19030516","volume":"19","author":"B Maloney","year":"2026","unstructured":"Maloney B, Kubisztal M, Ge Z. Efficacious anti-cancer drugs targeting nicotinamide N-methyltransferase (NNMT) in cultured human oral squamous cell carcinoma (OSCC). Pharmaceuticals (Basel). 2026;19(3):516.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"11","key":"16692_CR74","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1158\/0008-5472.CAN-15-0255","volume":"75","author":"MWL Teng","year":"2015","unstructured":"Teng MWL, et al. Classifying cancers based on T-cell infiltration and PD-L1. Cancer Res. 2015;75(11):2139\u201345.","journal-title":"Cancer Res"},{"key":"16692_CR75","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s40001-026-03945-5","volume":"31","author":"X Wei","year":"2026","unstructured":"Wei X, Chen L, Yang Z. PD-L1 status on circulating tumor cells: a promising predictor in advanced lung cancer with PD-1\/PD-L1 immunotherapies. Eur J Med Res. 2026;31:363.","journal-title":"Eur J Med Res"},{"issue":"4","key":"16692_CR76","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.it.2015.02.008","volume":"36","author":"KE Pauken","year":"2015","unstructured":"Pauken KE, Wherry EJ. Overcoming T cell exhaustion in infection and cancer. Trends Immunol. 2015;36(4):265\u201376.","journal-title":"Trends Immunol"},{"key":"16692_CR77","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13045-018-0669-2","volume":"11","author":"M Schlesinger","year":"2018","unstructured":"Schlesinger M. Role of platelets and platelet receptors in cancer metastasis. J Hematol Oncol. 2018;11:125.","journal-title":"J Hematol Oncol"},{"key":"16692_CR78","doi-asserted-by":"crossref","unstructured":"Tang D, Kang R. Platelet activation: a barrier to effective antitumor immunity, in Cancer Gene Ther. 2025: England. p. 741\u2013743.","DOI":"10.1038\/s41417-025-00915-7"},{"issue":"4","key":"16692_CR79","doi-asserted-by":"publisher","first-page":"e0152402","DOI":"10.1371\/journal.pone.0152402","volume":"11","author":"PC Elwood","year":"2016","unstructured":"Elwood PC, Morgan G, Pickering JE. Aspirin in the treatment of cancer: reductions in metastatic spread and in mortality: a systematic review and meta-analyses of published studies. PLoS ONE. 2016;11(4):e0152402.","journal-title":"PLoS ONE"},{"key":"16692_CR80","unstructured":"Cancer Research, U.K., Aspirin and Cancer."},{"issue":"7","key":"16692_CR81","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s12032-025-02787-1","volume":"42","author":"SO Rab","year":"2025","unstructured":"Rab SO, Altalbawy FMA, Bishoyi AK. Targeting platelet-tumor cell interactions: a novel approach to cancer therapy. Med Oncol. 2025;42(7):232.","journal-title":"Med Oncol"},{"key":"16692_CR82","doi-asserted-by":"crossref","unstructured":"Maloney B et al. Efficacious Anti-Cancer Drugs Targeting Nicotinamide N-Methyltransferase (NNMT) in Cultured Human Oral Squamous Cell Carcinoma (OSCC), in Pharmaceuticals (Basel). 2026: Switzerland.","DOI":"10.20944\/preprints202602.1087.v1"},{"key":"16692_CR83","unstructured":"Andresen NK et al. Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors - a biomarker analysis of the ALICE and ICON trials, in Mol Oncol. 2025: United States. p. 2092\u20132108."},{"key":"16692_CR84","unstructured":"Ankyra Therapeutics, I., A Phase 1b, Two-Part Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1\/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer. 2025."},{"key":"16692_CR85","doi-asserted-by":"crossref","unstructured":"Martin-Abreu C et al. Antiplatelet therapy mitigates brain metastasis risk in non-small cell lung cancer: insights from a comprehensive retrospective study, in Cancers (Basel). 2025: Switzerland.","DOI":"10.3390\/cancers17132059"},{"key":"16692_CR86","doi-asserted-by":"crossref","unstructured":"Teng M.W et al. Classifying Cancers Based on T-cell Infiltration and PD-L1, in Cancer Res. 2015: United States. p. 2139\u201345.","DOI":"10.1158\/0008-5472.CAN-15-0255"},{"issue":"6","key":"16692_CR87","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ccell.2018.03.002","volume":"33","author":"M Haemmerle","year":"2018","unstructured":"Haemmerle M, Stone RL, Menter DG. The platelet lifeline to cancer: challenges and opportunities. Cancer Cell. 2018;33(6):965\u201383.","journal-title":"Cancer Cell"},{"key":"16692_CR88","first-page":"178","volume":"33","author":"S Kim","year":"2025","unstructured":"Kim S, Park J, Lee J. Pharmacokinetics and pharmacodynamics of tirofiban in patients with cancer. Support Care Cancer. 2025;33:178.","journal-title":"Support Care Cancer"},{"issue":"2","key":"16692_CR89","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","volume":"378","author":"MA Postow","year":"2018","unstructured":"Postow MA, Sidlow R, Hellmann MD. Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med. 2018;378(2):158\u201368.","journal-title":"N Engl J Med"},{"issue":"1","key":"16692_CR90","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12935-025-03877-w","volume":"25","author":"J Gan","year":"2025","unstructured":"Gan J, Zhang X, Guo J. The role of platelets in tumor immune evasion and metastasis: mechanisms and therapeutic implications. Cancer Cell Int. 2025;25(1):258.","journal-title":"Cancer Cell Int"},{"key":"16692_CR91","doi-asserted-by":"crossref","unstructured":"Wei X et al. PD-L1 status on circulating tumor cells: a promising predictor in advanced lung cancer with PD-1\/PD-L1 immunotherapies, in Eur J Med Res. 2026: England.","DOI":"10.21203\/rs.3.rs-7920255\/v1"},{"key":"16692_CR92","unstructured":"Multi-Omic Features and Clustering Phenotypes of Circulating Tumor Cells Associated with Metastasis and Clinical Outcomes. 2025, Academic Press."},{"key":"16692_CR93","doi-asserted-by":"crossref","unstructured":"Tsigkas G et al. Dual Antiplatelet Therapy and Cancer; Balancing between Ischemic and Bleeding Risk: A Narrative Review, in J Cardiovasc Dev Dis. 2023: Switzerland.","DOI":"10.3390\/jcdd10040135"},{"issue":"7","key":"16692_CR94","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.1021\/acsomega.4c08606","volume":"10","author":"MA Mansor","year":"2025","unstructured":"Mansor MA, Yang C, Chong KL. Label-free and rapid microfluidic design rules for circulating tumor cell enrichment and isolation: a review and simulation analysis. ACS Omega. 2025;10(7):6306\u201322.","journal-title":"ACS Omega"},{"key":"16692_CR95","doi-asserted-by":"crossref","unstructured":"Su Y et al. Targeting circulating tumor cell\u2012neutrophil interactions: nanoengineered strategies for inhibiting cancer metastasis, in J Nanobiotechnology. 2025: England. p. 449.","DOI":"10.1186\/s12951-025-03522-8"},{"issue":"5","key":"16692_CR96","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"11","key":"16692_CR97","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.trecan.2021.07.001","volume":"7","author":"E Schuster","year":"2021","unstructured":"Schuster E, et al. Better together: circulating tumor cell clustering in metastatic cancer. Trends Cancer. 2021;7(11):1020\u201332.","journal-title":"Trends Cancer"},{"key":"16692_CR98","doi-asserted-by":"publisher","first-page":"1519816","DOI":"10.3389\/fonc.2024.1519816","volume":"14","author":"C Nicolazzo","year":"2024","unstructured":"Nicolazzo C, et al. Editorial: unveiling the potential of CTCs in drug resistance mechanisms and personalized medicine. Front Oncol. 2024;14:1519816.","journal-title":"Front Oncol"},{"key":"16692_CR99","unstructured":"Sahai E et al. A framework for advancing our understanding of cancer-associated fibroblasts, in Nat Rev Cancer. 2020: England. p. 174\u2013186."},{"issue":"13","key":"16692_CR100","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.3390\/cancers17132059","volume":"17","author":"C Mart\u00edn-Abreu","year":"2025","unstructured":"Mart\u00edn-Abreu C, Garc\u00eda-Gil M, M\u00e9ndez-Monge M. Antiplatelet therapy mitigates brain metastasis risk in non-small cell lung cancer: insights from a comprehensive retrospective study. Cancers (Basel). 2025;17(13):2059.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"16692_CR101","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.molonc.2008.04.001","volume":"2","author":"L Fass","year":"2008","unstructured":"Fass L. Imaging and cancer: a review. Mol Oncol. 2008;2(2):115\u201352.","journal-title":"Mol Oncol"},{"issue":"4","key":"16692_CR102","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nrc2621","volume":"9","author":"B Psaila","year":"2009","unstructured":"Psaila B, Lyden D. The metastatic niche: adapting the foreign soil. Nat Rev Cancer. 2009;9(4):285\u201393.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"16692_CR103","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ncb3169","volume":"17","author":"B Costa-Silva","year":"2015","unstructured":"Costa-Silva B, Aiello NM, Ocean AJ. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol. 2015;17(6):816\u201326.","journal-title":"Nat Cell Biol"},{"issue":"3\u20134","key":"16692_CR104","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10555-013-9420-1","volume":"32","author":"J Sceneay","year":"2013","unstructured":"Sceneay J, Smyth MJ, M\u00f6ller A. The pre-metastatic niche: finding common ground. Cancer Metastasis Rev. 2013;32(3\u20134):449\u201364.","journal-title":"Cancer Metastasis Rev"},{"issue":"5","key":"16692_CR105","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrc.2017.6","volume":"17","author":"H Peinado","year":"2017","unstructured":"Peinado H, Zhang H, Matei IR. Pre-metastatic niches: organ-specific homes for metastases. Nat Rev Cancer. 2017;17(5):302\u201317.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"16692_CR106","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/ncb1507","volume":"8","author":"S Hiratsuka","year":"2006","unstructured":"Hiratsuka S, et al. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol. 2006;8(12):1369\u201375.","journal-title":"Nat Cell Biol"},{"issue":"7069","key":"16692_CR107","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/nature04186","volume":"438","author":"RN Kaplan","year":"2005","unstructured":"Kaplan RN, Riba RD, Zacharoulis S. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005;438(7069):820\u20137.","journal-title":"Nature"},{"key":"16692_CR108","unstructured":"Ole Miss N. Researchers Break Cancer's 'Shield' in New Metastasis Study. 2025."},{"key":"16692_CR109","unstructured":"Wang Z et al. NNMT enriches for AQP5+ cancer stem cells to drive malignant progression in early gastric cardia adenocarcinoma. Gut, 2023: p. n. pag."},{"issue":"1","key":"16692_CR110","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ccr.2008.11.012","volume":"15","author":"JT Erler","year":"2009","unstructured":"Erler JT, Bennewith KL, Cox TR. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell. 2009;15(1):35\u201344.","journal-title":"Cancer Cell"},{"issue":"6","key":"16692_CR111","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1158\/0008-5472.CAN-12-2233","volume":"73","author":"TR Cox","year":"2013","unstructured":"Cox TR, Bird D, Baker A-M. LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis. Cancer Res. 2013;73(6):1721\u201332.","journal-title":"Cancer Res"},{"issue":"2","key":"16692_CR112","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.semcancer.2011.01.002","volume":"21","author":"P H\u00e9ctor","year":"2011","unstructured":"H\u00e9ctor P, Simon L, David L. The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin Cancer Biol. 2011;21(2):139\u201346.","journal-title":"Semin Cancer Biol"},{"key":"16692_CR113","doi-asserted-by":"crossref","unstructured":"Sceneay J et al. Tracking the fate of adoptively transferred myeloid-derived suppressor cells in the primary breast tumor microenvironment, in PLoS One. 2018: United States. p. e0196040.","DOI":"10.1371\/journal.pone.0196040"},{"key":"16692_CR114","doi-asserted-by":"crossref","unstructured":"Jung K et al. Elevated ARG1 expression in primary monocytes-derived macrophages as a predictor of radiation-induced acute skin toxicities in early breast cancer patients, in Cancer Biol Ther. 2015: United States. p. 1281\u20138.","DOI":"10.1080\/15384047.2015.1056945"},{"issue":"6119","key":"16692_CR115","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1126\/science.1228522","volume":"339","author":"M Yu","year":"2013","unstructured":"Yu M, Bardia A, Wittner BS. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science. 2013;339(6119):580\u20134.","journal-title":"Science"},{"issue":"7655","key":"16692_CR116","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature22364","volume":"545","author":"C Abbosh","year":"2017","unstructured":"Abbosh C, Birkbak NJ, Wilson GA. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature. 2017;545(7655):446\u201351.","journal-title":"Nature"},{"issue":"8","key":"16692_CR117","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41568-018-0016-5","volume":"18","author":"A Hosny","year":"2018","unstructured":"Hosny A, et al. Artificial intelligence in radiology. Nat Rev Cancer. 2018;18(8):500\u201310.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"16692_CR118","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nrc1886","volume":"6","author":"P Mehlen","year":"2006","unstructured":"Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer. 2006;6(6):449\u201358.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"16692_CR119","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","volume":"14","author":"UE Martinez-Outschoorn","year":"2017","unstructured":"Martinez-Outschoorn UE, et al. Cancer metabolism: a therapeutic perspective. Nat Rev Clin Oncol. 2017;14(1):11\u201331.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"16692_CR120","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1158\/2159-8290.CD-15-1483","volume":"6","author":"C Alix-Panabi\u00e8res","year":"2016","unstructured":"Alix-Panabi\u00e8res C, Pantel K. Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy. Cancer Discov. 2016;6(5):479\u201391.","journal-title":"Cancer Discov"},{"issue":"2","key":"16692_CR121","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1158\/1078-0432.CCR-14-0990","volume":"21","author":"JPB O'Connor","year":"2015","unstructured":"O\u2019Connor JPB, et al. Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome. Clin Cancer Res. 2015;21(2):249\u201357.","journal-title":"Clin Cancer Res"},{"issue":"6409","key":"16692_CR122","doi-asserted-by":"publisher","first-page":"eaao4227","DOI":"10.1126\/science.aao4227","volume":"361","author":"J Albrengues","year":"2018","unstructured":"Albrengues J, Shields MA, Ng D. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science. 2018;361(6409):eaao4227.","journal-title":"Science"},{"issue":"7","key":"16692_CR123","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nrc3958","volume":"15","author":"HE Barker","year":"2015","unstructured":"Barker HE, et al. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer. 2015;15(7):409\u201325.","journal-title":"Nat Rev Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16692-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16692-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16692-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:05:48Z","timestamp":1789034748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16692-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":123,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16692"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16692-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"10 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest or financial ties to disclose.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1085"}}